IL-1-话题@MedSci

#IL-1#

184篇内容 | 4459人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1508273, encodeId=325e15082e3b0, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=Hypertension：IL-1受体拮抗剂可增加肥胖个体Ang（1-7)水平并降低血压, objectType=article, longId=192113, objectId=ac2e192113e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac2e192113e5, replyNumber=0, likeNumber=75, createdTime=2020-04-14, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac2e192113e5, moduleTitle=Hypertension：IL-1受体拮抗剂可增加肥胖个体Ang（1-7)水平并降低血压, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ac2e192113e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508272, encodeId=316615082e231, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=JCI Insight：阻断IL-10受体信号转导可改善流感诱发的肺结核分枝杆菌感染过程中的病情恶化, objectType=article, longId=191598, objectId=3a5519159855, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a5519159855, replyNumber=0, likeNumber=69, createdTime=2020-04-08, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a5519159855, moduleTitle=JCI Insight：阻断IL-10受体信号转导可改善流感诱发的肺结核分枝杆菌感染过程中的病情恶化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a5519159855)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508271, encodeId=8f3715082e10b, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=赛诺菲的IL-4/IL-13单抗Dupixent，在特应性皮炎儿童患者中显示出明显益处, objectType=article, longId=191379, objectId=18d21913e93a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=18d21913e93a, replyNumber=0, likeNumber=98, createdTime=2020-04-05, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=18d21913e93a, moduleTitle=赛诺菲的IL-4/IL-13单抗Dupixent，在特应性皮炎儿童患者中显示出明显益处, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=18d21913e93a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508270, encodeId=faff15082e0b4, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=Cell Death Dis：肿瘤微环境浸润B细胞通过IL-1β/HIF-2α/ Notch1信号促进肾癌转移, objectType=article, longId=190441, objectId=8ef8190441e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ef8190441e0, replyNumber=0, likeNumber=76, createdTime=2020-03-21, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ef8190441e0, moduleTitle=Cell Death Dis：肿瘤微环境浸润B细胞通过IL-1β/HIF-2α/ Notch1信号促进肾癌转移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ef8190441e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508269, encodeId=dde91508269fc, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=Medicine：PSEP，TNF-α和IL-10用于联合诊断前列腺炎, objectType=article, longId=189438, objectId=b51518943807, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b51518943807, replyNumber=0, likeNumber=71, createdTime=2020-03-07, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b51518943807, moduleTitle=Medicine：PSEP，TNF-α和IL-10用于联合诊断前列腺炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b51518943807)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508268, encodeId=96231508268be, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=J Hepatology： IL-17在脂肪性肝细胞和巨噬细胞中促进酒精相关性肝病中的肝细胞癌的发生, objectType=article, longId=188602, objectId=0572188602fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0572188602fa, replyNumber=0, likeNumber=61, createdTime=2020-02-24, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0572188602fa, moduleTitle=J Hepatology： IL-17在脂肪性肝细胞和巨噬细胞中促进酒精相关性肝病中的肝细胞癌的发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0572188602fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508267, encodeId=efe3150826e48, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=Circulation：缺血再灌注损伤时释放的内皮细胞来源的IL-18可选择性地扩增T外周辅助细胞以促进同种抗体的产生, objectType=article, longId=188240, objectId=52c3188240b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=52c3188240b2, replyNumber=0, likeNumber=90, createdTime=2020-02-18, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=52c3188240b2, moduleTitle=Circulation：缺血再灌注损伤时释放的内皮细胞来源的IL-18可选择性地扩增T外周辅助细胞以促进同种抗体的产生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=52c3188240b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508266, encodeId=279b150826668, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=Janssen宣布其IL-12/IL-23单抗Stelara治疗克罗恩病的III期中期分析阳性结果, objectType=article, longId=188168, objectId=b557188168d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b557188168d1, replyNumber=0, likeNumber=63, createdTime=2020-02-17, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b557188168d1, moduleTitle=Janssen宣布其IL-12/IL-23单抗Stelara治疗克罗恩病的III期中期分析阳性结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b557188168d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508265, encodeId=09b31508265af, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=被英国NICE拒绝后，强生的IL-23/IL-12单抗Stelara获得欧盟扩展适应症治疗儿童牛皮癣, objectType=article, longId=187183, objectId=a1b618e18333, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a1b618e18333, replyNumber=0, likeNumber=64, createdTime=2020-02-03, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a1b618e18333, moduleTitle=被英国NICE拒绝后，强生的IL-23/IL-12单抗Stelara获得欧盟扩展适应症治疗儿童牛皮癣, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a1b618e18333)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508264, encodeId=820c1508264c5, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=J Rheumatol：IL-17A和IL-17F在类风湿性关节炎和外周型脊椎关节炎中的表达及功能反应, objectType=article, longId=186528, objectId=ba8f18652830, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba8f18652830, replyNumber=0, likeNumber=53, createdTime=2020-01-21, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba8f18652830, moduleTitle=J Rheumatol：IL-17A和IL-17F在类风湿性关节炎和外周型脊椎关节炎中的表达及功能反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba8f18652830)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508263, encodeId=7e56150826344, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=礼来宣布以11亿美元收购Dermira，同时获得中度至重度特应性皮炎III期IL-13单抗lebrikizumab, objectType=article, longId=186390, objectId=85b418639058, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=85b418639058, replyNumber=0, likeNumber=89, createdTime=2020-01-18, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=85b418639058, moduleTitle=礼来宣布以11亿美元收购Dermira，同时获得中度至重度特应性皮炎III期IL-13单抗lebrikizumab, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=85b418639058)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508262, encodeId=ffd01508262d1, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=头对头牛皮癣临床研究，艾伯维的IL-23单抗Skyrizi显着优于诺华的IL-17单抗Cosentyx, objectType=article, longId=186385, objectId=ced718638553, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ced718638553, replyNumber=0, likeNumber=75, createdTime=2020-01-18, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ced718638553, moduleTitle=头对头牛皮癣临床研究，艾伯维的IL-23单抗Skyrizi显着优于诺华的IL-17单抗Cosentyx, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ced718638553)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508261, encodeId=a01e150826157, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=Sci Rep：非小细胞肺癌中IL-1β诱导的慢性炎症通过表观遗传修饰调节EMT记忆表型, objectType=article, longId=186368, objectId=b9b618636880, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b9b618636880, replyNumber=0, likeNumber=69, createdTime=2020-01-18, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b9b618636880, moduleTitle=Sci Rep：非小细胞肺癌中IL-1β诱导的慢性炎症通过表观遗传修饰调节EMT记忆表型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b9b618636880)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508260, encodeId=2ee315082603a, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=LEO pharma的IL-13单抗在III期特应性皮炎临床研究中达到实验终点, objectType=article, longId=184948, objectId=7e421849487b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e421849487b, replyNumber=0, likeNumber=70, createdTime=2019-12-21, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e421849487b, moduleTitle=LEO pharma的IL-13单抗在III期特应性皮炎临床研究中达到实验终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e421849487b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508259, encodeId=6845150825913, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=头对头III期牛皮癣研究证实，UCB的IL-17A / IL-17F单抗bimekizumab优于AbbVie的TNF单抗Humira, objectType=article, longId=184396, objectId=e1d618439611, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e1d618439611, replyNumber=0, likeNumber=0, createdTime=2019-12-09, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e1d618439611, moduleTitle=头对头III期牛皮癣研究证实，UCB的IL-17A / IL-17F单抗bimekizumab优于AbbVie的TNF单抗Humira, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e1d618439611)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508258, encodeId=d6861508258a5, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=2019年神经肿瘤学会：IL-12治疗复发性胶质母细胞瘤的临床数据, objectType=article, longId=183565, objectId=c2ab183565aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c2ab183565aa, replyNumber=0, likeNumber=70, createdTime=2019-11-26, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c2ab183565aa, moduleTitle=2019年神经肿瘤学会：IL-12治疗复发性胶质母细胞瘤的临床数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c2ab183565aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508257, encodeId=1e2f150825e60, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=JCC： IL-13 mRNA组织含量可鉴定成年溃疡性结肠炎患者的两个亚组, objectType=article, longId=182743, objectId=0e45182e43c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e45182e43c1, replyNumber=0, likeNumber=73, createdTime=2019-11-10, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e45182e43c1, moduleTitle=JCC： IL-13 mRNA组织含量可鉴定成年溃疡性结肠炎患者的两个亚组, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e45182e43c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508256, encodeId=bc691508256d1, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=JCC：IL-6缺失会加剧IL-10缺乏小鼠的结肠炎并诱发全身性炎症, objectType=article, longId=182741, objectId=0ddc182e4189, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ddc182e4189, replyNumber=0, likeNumber=52, createdTime=2019-11-10, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ddc182e4189, moduleTitle=JCC：IL-6缺失会加剧IL-10缺乏小鼠的结肠炎并诱发全身性炎症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ddc182e4189)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508255, encodeId=6383150825524, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=银屑病关节炎头对头实验中，诺华的IL-17单抗Cosentyx与Humira相比未能实现统计学意义的改善, objectType=article, longId=182337, objectId=c39f18233ed9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c39f18233ed9, replyNumber=0, likeNumber=0, createdTime=2019-11-05, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c39f18233ed9, moduleTitle=银屑病关节炎头对头实验中，诺华的IL-17单抗Cosentyx与Humira相比未能实现统计学意义的改善, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c39f18233ed9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508254, encodeId=8cd81508254c8, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=强生宣布其IL-12/IL-23单抗STELARA（ustekinumab）喜获FDA批准治疗中度至重度活动性溃疡性结肠炎, objectType=article, longId=181708, objectId=3487181e0866, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3487181e0866, replyNumber=0, likeNumber=33, createdTime=2019-10-23, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3487181e0866, moduleTitle=强生宣布其IL-12/IL-23单抗STELARA（ustekinumab）喜获FDA批准治疗中度至重度活动性溃疡性结肠炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3487181e0866)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

IL-1

2020-05-29

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

Hypertension：IL-1受体拮抗剂可增加肥胖个体Ang（1-7)水平并降低血压

2020-04-14

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

JCI Insight：阻断IL-10受体信号转导可改善流感诱发的肺结核分枝杆菌感染过程中的病情恶化

2020-04-08

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

赛诺菲的IL-4/IL-13单抗Dupixent，在特应性皮炎儿童患者中显示出明显益处

2020-04-05

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

Cell Death Dis：肿瘤微环境浸润B细胞通过IL-1β/HIF-2α/ Notch1信号促进肾癌转移

2020-03-21

一叶知秋 (审核中...)

前往app查看评论内容

#IL-1#

Medicine：PSEP，TNF-α和IL-10用于联合诊断前列腺炎

2020-03-07

一叶知秋 (审核中...)

前往app查看评论内容

#IL-1#

J Hepatology： IL-17在脂肪性肝细胞和巨噬细胞中促进酒精相关性肝病中的肝细胞癌的发生

2020-02-24

一叶知秋 (审核中...)

前往app查看评论内容

#IL-1#

Circulation：缺血再灌注损伤时释放的内皮细胞来源的IL-18可选择性地扩增T外周辅助细胞以促进同种抗体的产生

2020-02-18

一叶知秋 (审核中...)

前往app查看评论内容

#IL-1#

Janssen宣布其IL-12/IL-23单抗Stelara治疗克罗恩病的III期中期分析阳性结果

2020-02-17

一叶知秋 (审核中...)

前往app查看评论内容

#IL-1#

被英国NICE拒绝后，强生的IL-23/IL-12单抗Stelara获得欧盟扩展适应症治疗儿童牛皮癣

2020-02-03

一叶知秋 (审核中...)

前往app查看评论内容

#IL-1#

J Rheumatol：IL-17A和IL-17F在类风湿性关节炎和外周型脊椎关节炎中的表达及功能反应

2020-01-21

一叶知秋 (审核中...)

前往app查看评论内容

#IL-1#

礼来宣布以11亿美元收购Dermira，同时获得中度至重度特应性皮炎III期IL-13单抗lebrikizumab

2020-01-18

一叶知秋 (审核中...)

前往app查看评论内容

#IL-1#

头对头牛皮癣临床研究，艾伯维的IL-23单抗Skyrizi显着优于诺华的IL-17单抗Cosentyx

2020-01-18

一叶知秋 (审核中...)

前往app查看评论内容

#IL-1#

Sci Rep：非小细胞肺癌中IL-1β诱导的慢性炎症通过表观遗传修饰调节EMT记忆表型

2020-01-18

一叶知秋 (审核中...)

前往app查看评论内容

#IL-1#

LEO pharma的IL-13单抗在III期特应性皮炎临床研究中达到实验终点

2019-12-21

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

头对头III期牛皮癣研究证实，UCB的IL-17A / IL-17F单抗bimekizumab优于AbbVie的TNF单抗Humira

2019-12-09

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

2019年神经肿瘤学会：IL-12治疗复发性胶质母细胞瘤的临床数据

2019-11-26

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

JCC： IL-13 mRNA组织含量可鉴定成年溃疡性结肠炎患者的两个亚组

2019-11-10

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

JCC：IL-6缺失会加剧IL-10缺乏小鼠的结肠炎并诱发全身性炎症

2019-11-10

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

银屑病关节炎头对头实验中，诺华的IL-17单抗Cosentyx与Humira相比未能实现统计学意义的改善

2019-11-05

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

强生宣布其IL-12/IL-23单抗STELARA（ustekinumab）喜获FDA批准治疗中度至重度活动性溃疡性结肠炎

2019-10-23

科室
- - 订阅+
  - 更多科室
工具
服务